Obstructive Sleep Apnea Hypopnea
1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Ventus TherapeuticsMA - Waltham
2 programs1
Provent Professional Sleep Apnea Therapy DevicePhase 41 trial
Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopneaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Ventus TherapeuticsProvent Professional Sleep Apnea Therapy Device
Ventus TherapeuticsExtension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
Clinical Trials (2)
Total enrollment: 315 patients across 2 trials
Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea
Start: Nov 2008Est. completion: Dec 2009250 patients
Phase 4Completed
NCT00849043Ventus TherapeuticsExtension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
Start: Feb 2009Est. completion: Oct 201065 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space